TP53 and cancer: Importantly, Sirt7+/−p53−/− mice, compared to Sirt7+/+p53−/− mice, present a significantly higher tumor formation (Figure 2A) and a more aggressive cancer progression as histopathological analysis revealed tumor dissemination to different organs (Figure 2B).